JPMorgan Chase & Co’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-112,536
| Closed | -$270K | – | 5005 |
|
|
2019
Q2 | $270K | Buy |
112,536
+22,027
| +24% | +$52.8K | ﹤0.01% | 3652 |
|
|
2019
Q1 | $339K | Buy |
+90,509
| New | +$339K | ﹤0.01% | 3544 |
|
|
2018
Q3 | – | Sell |
-60,488
| Closed | -$303K | – | 4939 |
|
|
2018
Q2 | $303K | Buy |
+60,488
| New | +$303K | ﹤0.01% | 3658 |
|
|
2017
Q4 | – | Sell |
-217
| Closed | -$1K | – | 4786 |
|
|
2017
Q3 | $1K | Sell |
217
-11,589
| -98% | -$53.4K | ﹤0.01% | 4258 |
|
|
2017
Q2 | $55K | Buy |
+11,806
| New | +$55K | ﹤0.01% | 3726 |
|
|
2017
Q1 | – | Sell |
-611
| Closed | -$7K | – | 4608 |
|
|
2016
Q4 | $7K | Buy |
+611
| New | +$7K | ﹤0.01% | 4303 |
|
|
2016
Q2 | – | Sell |
-188,925
| Closed | -$1.23M | – | 4442 |
|
|
2016
Q1 | $1.23M | Sell |
188,925
-17,075
| -8% | -$111K | ﹤0.01% | 2593 |
|
|
2015
Q4 | $1.67M | Buy |
+206,000
| New | +$1.67M | ﹤0.01% | 2458 |
|
|
2015
Q1 | – | Sell |
-732,890
| Closed | -$5.14M | – | 3566 |
|
|
2014
Q4 | $5.14M | Buy |
732,890
+132,890
| +22% | +$932K | ﹤0.01% | 2041 |
|
|
2014
Q3 | $3.27M | Buy |
+600,000
| New | +$3.27M | ﹤0.01% | 2206 |
|